Alpha-1 Study – Ages 14-17

If your child has Alpha-1-Antitrypsin deficiency (ATD) and liver disease, he or she may be able to participate in a research study to find out if the drug carbamazepine (Tegretol®) can help to prevent or treat liver disease in people with ATD. Participants receive carbamazepine or a placebo for one year. Travel expenses compensated.